Developing a vaccine to prevent Chlamydia trachomatis infections
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
This study is working on a new vaccine to help protect people from Chlamydia, a common sexually transmitted infection, using advanced technology to make it more effective, so that everyone can have a better way to stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lawrence Livermore National Security, LLC NIH-funded |
| Lab location | 1 site (Livermore, United States) |
| Project ID | NIH-10694893 on NIH RePORTER |
What this research studies
This research aims to create a vaccine for Chlamydia trachomatis, a common sexually transmitted infection that affects millions globally. The project involves a collaborative effort among various institutions to utilize innovative nano-formulated vaccine technologies. By engineering nanolipoprotein particles, the research seeks to enhance the delivery and effectiveness of the vaccine, addressing the challenges faced in previous vaccine development efforts. Patients may benefit from a new preventive measure against the health complications associated with this infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of Chlamydia trachomatis infections, particularly sexually active adults and adolescents.
Not a fit: Patients who are not sexually active or those who have already been infected with Chlamydia trachomatis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a much-needed vaccine to prevent Chlamydia trachomatis infections and their associated health complications.
How similar studies have performed: While there have been challenges in developing a Chlamydia vaccine, previous studies have shown promise with certain immunization strategies, making this approach both innovative and necessary.
Where this research is happening
Livermore, United States
- Lawrence Livermore National Security, LLC — Livermore, United States (Active)
Researchers
- Principal investigator: Coleman, Matthew Adrian — Lawrence Livermore National Security, LLC
- Study coordinator: Coleman, Matthew Adrian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.